SSA
COCH icon

Schonfeld Strategic Advisors’s Envoy Medical COCH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,201
Closed -$130K – 2644
2022
Q3 		$130K Hold
13,201
– – ﹤0.01% 2484
2022
Q2 		$129K Hold
13,201
– – ﹤0.01% 2070
2022
Q1 		$129K Sell
13,201
-27,699
-68% -$270K ﹤0.01% 2160
2021
Q4 		$398K Buy
+40,900
New +$399K ﹤0.01% 1387

Other funds holding COCH

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

Schonfeld Strategic Advisors's COCH Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Envoy Medical (COCH) in Q4 2022, closing a stake of 13,201 shares — an estimated $130K sold.

Schonfeld Strategic Advisors first reported a position in COCH in Q4 2021 and held it in 4 quarters. The position peaked at $398K in Q4 2021. 93 funds tracked by Wall St. Rank hold COCH as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining Envoy Medical position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 13,201 Envoy Medical shares in Q4 2022, an estimated $130K.
  • Schonfeld Strategic Advisors first reported a position in Envoy Medical in Q4 2021 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Envoy Medical position peaked at $398K in Q4 2021.
  • 93 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.